Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vismodegib in Combination With Temozolomide Versus Temozolomide Alone in Adult Patients With Recurrent or Refractory Medulloblastomas
NCT01601184Phase 2Terminated
- Sponsor
- Centre Léon Bérard
- Start
- Jun 2012
- Primary completion
- Sep 2017
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 2 trial of vismodegib in medulloblastoma, sponsored by Centre Léon Bérard. Started Jun 2012; status: terminated.
02
Drugs
vismodegib
03
Conditions
medulloblastoma
Beyond the preview
Go deeper on NCT01601184.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01601184.